menu
    • menu

    Company profile for Antibe Therapeutics

    NEW Drugs in Dev: 2
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Antibe Therapeutics (“Antibe”) is a public biotech company with a drug platform of game-changing therapeutics in pain and inflammation. Its lead drug, ATB-346, recently showed unequivocal superiority to naproxen in GI safety, and its combined pipeline is targeting a global market opportunity in excess of $20 billion. Antibe’s commercial division in regenerative medicine is on a growth trajectory in the dental biologics m...
    Antibe Therapeutics (“Antibe”) is a public biotech company with a drug platform of game-changing therapeutics in pain and inflammation. Its lead drug, ATB-346, recently showed unequivocal superiority to naproxen in GI safety, and its combined pipeline is targeting a global market opportunity in excess of $20 billion. Antibe’s commercial division in regenerative medicine is on a growth trajectory in the dental biologics market.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Antibe TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    15 Prince Arthur Avenue Toronto, Ontario M5R 1B2 Canada
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.antibethera.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/antibe-therapeutics-inc/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/antibethera?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Antibe Announces Completion of Sale
    Antibe Announces Completion of Sale

    18 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/18/3044874/0/en/Antibe-Announces-Completion-of-Sale.html

    GLOBENEWSWIRE
    18 Mar 2025
    Share Share
    Sun Pharma subsidiary Taro acquires Antibe Therapeutics
    Sun Pharma subsidiary Taro acquires Antibe Therapeutics

    16 Jan 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/sun-pharma-subsidiary-taro-acquires-antibe-therapeutics/

    EXPRESSPHARMA
    16 Jan 2025
    Share Share
    Antibe Announces Appointment of Receiver
    Antibe Announces Appointment of Receiver

    24 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240424042966/en

    BUSINESSWIRE
    24 Apr 2024
    Share Share
    Antibe Provides Update on CCAA Proceedings
    Antibe Provides Update on CCAA Proceedings

    19 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240419229842/en

    BUSINESSWIRE
    19 Apr 2024
    Share Share
    Antibe Announces TSX Delisting Review
    Antibe Announces TSX Delisting Review

    16 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240416152611/en

    BUSINESSWIRE
    16 Apr 2024
    Share Share
    Antibe Receives Initial Order Under Creditors' Arrangement Act
    Antibe Receives Initial Order Under Creditors' Arrangement Act

    10 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240409669936/en

    BUSINESSWIRE
    10 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search